Company intelligence / Profile preview

Anik Capital

Bedford, Massachusetts, United Stateshightideinc.com ↗

Ownership: Private
Employees: ~357
Development stage: Other

Overview

Anika's commercialized HA-based viscosupplements are established in osteoarthritis pain management. Regenerative Solutions segment is growing rapidly with strong demand for the Integrity Implant System (+40% QoQ). Cingal awaits potential U.S. approval; Hyalofast launch expected to drive further growth.

Therapeutic areas: RheumatologyOther
Modalities: BiologicDeviceSmall molecule
Industry: Biotech

Partnerships

J&J Medtech partnership on OA Pain Management distribution/products.

Beyond the preview

Go deeper on Anik Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anik Capital.

Explore the full profile